Medical/Pharmaceuticals

Hettigoda Industries Private Limited Awarded at the International Innovation Awards 2021 for Siddhalepa Pain Relief Spray

SINGAPORE, Dec. 20, 2021 /PRNewswire/ -- Enterprise Asia is pleased to honor 52 award recipients at the International Innovation Awards 2021. Spearheading the Innovation Revolution, the International Innovation Awards which aims to create an innovation ecosystem for enterprises is held annually...

2021-12-21 11:53 2479

The New Era Biotechnology Brings The Cooperation Between China And Belarus To A New Level

MINSK, Belarus, Dec. 21, 2021 /PRNewswire/ -- New Era Biotechnology Co., Ltd is an enterprise fromthe Great Stone China Belarus Industrial Park (CBIP) in Minsk . It participated in the fourth edition of the China International Import Expo (CIIE) which opened inShanghai on November 5, 2021.   Loc...

2021-12-21 08:04 3240

World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine

- Nuvaxovid™ COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]) listed for emergency use by the WHO - EUL for Nuvaxovid complements listing for Novavax vaccine manufactured and marketedby Serum Institute of India as Covovax™ - EUL by WHO is a prerequisite for exports to numerous countri...

2021-12-21 03:33 4332

European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine

* Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine authorized for use inEurope * Novavax and the European Commission previously announced an advance purchase agreement for up to 200 million doses through 2023 * Authorization follows positive r...

2021-12-21 03:28 4755

Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 Vaccine

* European Commission decision on conditional marketing authorization expected imminently * Upon authorization, Nuvaxovid™ (also known as NVX-CoV2373) will be the first protein-based COVID-19 vaccine available inEurope GAITHERSBURG, Md., Dec. 20, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NV...

2021-12-20 21:34 4260

Everest Medicines and Providence Therapeutics announces that PTX-COVID19-B, a mRNA Vaccine for COVID-19, has received approval for inclusion in WHO Solidarity Trial Vaccines (STV) Program

SHANGHAI, Dec. 20, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) and Providence Therapeutics ("Providence") announced today that their COVID-19 vaccine, PTX-COVID19-B, has been recommended by an independent advisory group to be part of the WHO Solidarity Trial Vaccines ("STV") clinical t...

2021-12-20 20:55 5129

Thailand BOI Approves Extension of Investment Acceleration Package, EEC Incentive Package and Additional Special Zones

BANGKOK, Dec. 20, 2021 /PRNewswire/ -- The Thailand Board of Investment (BOI) at a meeting today approved a number of policy measures, namely an extension of the investment acceleration package and EEC incentive package, special incentive package for Yothi Medical Innovation Zone and classificati...

2021-12-20 20:49 4050

2021 Sustainability Report of Sai Life Sciences highlights the momentum gained in its Sustainability choices

* Report developed as per Global Reporting Initiative (GRI) standards * Extensively deals with the company's response to the Covid-19 pandemic HYDERABAD, India, Dec. 20, 2021 /PRNewswire/ -- Sai Life Sciences, a leading globalContract Research, Development & Manufacturing Organization

2021-12-20 19:16 1408

Syntach AB awarded an EU grant of € 2.5 million

LUND, Sweden, Dec. 20, 2021 /PRNewswire/ -- Syntach AB in Lund, Sweden has been awarded € 2.5 million as a grant and part of blended finance of up to € 17,5 million from the European Innovation Council (EIC) to support the development of its unique minimally invasive cardiac support system. Over...

2021-12-20 15:00 3248

First Patient Dosed in Australia in ATG-101 First-in-Human Trial

SHANGHAI and HONG KONG, Dec. 20, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and onco...

2021-12-20 11:01 5016

Japan's MHLW Approves Booster Shot for SPIKEVAX®, Moderna's mRNA COVID-19 Vaccine

The SPIKEVAX® brand name was developed in partnership with Brand Institute, the global leader in pharmaceutical and healthcare-related name development MIAMI, Dec. 20, 2021 /PRNewswire/ -- Brand Institute is proud to announce its successful partnership with Moderna in naming their mRNA COVID-19 v...

2021-12-20 09:00 4919

Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine

* First EUL granted by WHO for a protein-based COVID-19 vaccine * EUL vaccine manufactured and marketed by SII as COVOVAX™ * WHO EUL for Nuvaxovid™ currently under assessment; will be completed following European Medicines Agency (EMA) review GAITHERSBURG, Md. and PUNE, India, Dec. 20, 2021 ...

2021-12-20 08:24 5636

Novo Nordisk among the top 3 Best Places to Work in Singapore for 2021

Singapore, Dec. 20, 2021 Novo Nordisk Singapore, an affiliate of the global healthcare company with more than 95 years of innovation and leadership in diabetes care, has recently been recognized among the top 3 Best Places to Work for 2021. During the assessment, the company received outsta...

2021-12-20 07:25 2578

Antengene Announces NDA Approval by NMPA for XPOVIO®, China's First XPO1 inhibitor, for the Treatment of Adults with Relapsed or Refractory Multiple Myeloma

SHANGHAI and HONG KONG, Dec. 17, 2021 /PRNewswire/ -- Antengene Corporation Limited (the "Company" or "Antengene") is pleased to announce thatATG-010 (selinexor, brand name:XPOVIO®), a first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) compound has received conditional approval for...

2021-12-17 22:27 6321

Westlake Omics Authorized as the Exclusive Distributor and Service Provider of Pressure BioSciences, Inc. in China

HANGZHOU, China, Dec. 17, 2021 /PRNewswire/ -- The Agreement signed by Westlake Omics (Hangzhou) Biotechnology Co., Ltd (hereinafter referred to as Westlake Omics) and Pressure BioSciences, Inc. (hereinafter referred to as PBI) on December 3, 2021 authorized Westlake Omics as the exclusive distrib...

2021-12-17 19:00 2425

Bioscience Animal Health Public Company Limited Accorded the International Innovation Awards 2021 for Angentex® COVID-19 qPCR Detection Kit

SINGAPORE, Dec. 17, 2021 /PRNewswire/ -- Enterprise Asia is pleased to honor 52 award recipients at the International Innovation Awards 2021. Spearheading the Innovation Revolution, the International Innovation Awards which aims to create an innovation ecosystem for enterprises is held annually t...

2021-12-17 18:24 2533

Study on Anti-aging with TCM Strides Forward

SHIJIAZHUANG, China, Dec. 17, 2021 /PRNewswire/ -- The opinions of experts on "Study on Anti-aging with Bazi Bushen Capsules Guided by Qi Collateral Theory" were released inShijiazhuang, Hebei on December 15. According to the opinions, the preliminary research of the project has created the theo...

2021-12-17 17:06 3669

Lipidor expands clinical program, announces investment in new drug development project against acne vulgaris

STOCKHOLM, Dec. 17, 2021 /PRNewswire/ -- Lipidor AB (publ) (Nasdaq First North: LIPI) today announces that it has initiated a preclinical program for a new drug candidate, AKP-08, focused on acne vulgaris (acne). The market for acne medicines amounts to about35 billion SEK per year, which togethe...

2021-12-17 16:10 2889

"academist" and Sysmex R&D Center Europe to Begin Collaborating in Exploring and Nurturing "Research Seeds" in Europe

TOKYO, Dec. 17, 2021 /PRNewswire/ -- academist, Inc., which operates Japan's first academic crowdfunding platform (https://academist-cf.com/?lang=en ), and Sysmex R&D Center Europe GmbH (hereinafter "Sysmex R&D Center Europe,"https://www.sysmex-rdce.com/

2021-12-17 14:00 2511

Transcenta Announces the Appointment of Daniel Weng as CFO

SUZHOU, China, Dec. 17, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the appointment of Da...

2021-12-17 08:30 4867
1 ... 359360361362363364365 ... 380